Quent Long Short Global Small Cap Fund’s Regeneron Pharmaceuticals REGN Stock Holding History

Quent Long Short Global Small Cap Fund’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$369K	Buy	+478	New	+$325K	0.03%	196

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Quent Long Short Global Small Cap Fund's REGN Position: Q4 2025 in Review

Quent Long Short Global Small Cap Fund opened a new position in Regeneron Pharmaceuticals (REGN) in Q4 2025: 478 shares worth $369K. The stake represents 0.03% of the portfolio and ranks #196 among its holdings.

1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

Quent Long Short Global Small Cap Fund held 478 shares of Regeneron Pharmaceuticals worth $369K as of Q4 2025.
Regeneron Pharmaceuticals was a new Quent Long Short Global Small Cap Fund position in Q4 2025.
Regeneron Pharmaceuticals made up 0.03% of Quent Long Short Global Small Cap Fund's portfolio in Q4 2025, its #196 holding.
1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on Quent Long Short Global Small Cap Fund's 13F filing for Q4 2025, filed 28 Jan 2026.